Jpmorgan Chase & CO Lucira Health, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$0.11 - $0.83 $120 - $906
1,092 Added 13650.0%
1,100 $0
Q3 2022

Nov 14, 2022
BUY
$1.27 - $3.39 $10 - $27
8 New
8 $0
Q1 2022

May 11, 2022
SELL
$2.86 - $8.83 $1,324 - $4,088
-463 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$4.94 - $8.94 $2,287 - $4,139
463 New
463 $4,000

Others Institutions Holding LHDX

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Lucira Health, Inc.

LHDX Quotes by TradingView
  • Ticker LHDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,106,500
  • Market Cap $1.2M
  • Description
  • Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a paten...
More about LHDX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email